Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin.
D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000150:complications / Q000188:drug therapy; D004573:Electrolytes / Q000097:blood / Q000652:urine; D004938:Esophageal Neoplasms / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000652:urine; D007677:Kidney Function Tests; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010014:Osteolysis / Q000188:drug therapy / Q000209:etiology; D008926:Plicamycin / Q000008:administration & dosage / Q000627:therapeutic use*
D004573:Electrolytes; D008926:Plicamycin